Non-alcoholic fatty liver disease.: From insulin resistance to mitochondrial dysfunction

被引:2
作者
Herruzo, J. A. Solis
Ruiz, I. Garcia
Carreras, M. Perez
Yague, M. T. Munoz
机构
[1] Univ Complutense Madrid, Hosp 12 Octubre, Ctr Invest,Dept Gastroenterol, Serv Med Aparato Digest,Ctra Andalucia,Res Ctr, Madrid 28041, Spain
[2] Univ Complutense Madrid, Hosp 12 Octubre, Res Ctr, Dept Hepatol, Madrid 28041, Spain
关键词
non-alcoholic fatty liver disease; insulin resistance; mitochondrial dysfunction;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease represents a set of liver lesions similar to those induced by alcohol that develop in individuals with no alcohol abuse. When lesions consist of fatty and hydropic degeneration, inflammation, and eventually fibrosis, the condition is designated non-alcoholic steatohepatitis (NASH). The pathogenesis of these lesions is not clearly understood, but they are associated with insulin resistance in most cases. As a result, abdominal fat tissue lipolysis and excessive fatty acid uptake by the liver occur. This, together with a disturbance of triglyceride export as VLDL, results in fatty liver development. Both the inflammatory and hepatocellular degenerative components of NASH are attributed to oxidative stress. Mitochondrial respiratory chain loss of activity plays a critical role in the genesis of latter stress. This may be initiated by an increase in the hepatic TNF alpha, iNOS induction, peroxynitrite formation, tyrosine nitration and inactivation of enzymes making up this chain. Consequences of oxidative stress include: lipid peroxidation in cell membranes, stellate cell activation in the liver, liver fibrosis, chronic inflammation, and apoptosis.
引用
收藏
页码:844 / 863
页数:20
相关论文
共 329 条
[81]   Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway [J].
Feldstein, AE ;
Werneburg, NW ;
Canbay, A ;
Guicciardi, ME ;
Bronk, SF ;
Rydzewski, R ;
Burgart, LJ ;
Gores, GJ .
HEPATOLOGY, 2004, 40 (01) :185-194
[82]   Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis [J].
Feldstein, AE ;
Canbay, A ;
Angulo, P ;
Taniai, M ;
Burgart, LJ ;
Lindor, KD ;
Gores, GJ .
GASTROENTEROLOGY, 2003, 125 (02) :437-443
[83]   Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse [J].
Ferret, PJ ;
Hammoud, R ;
Tulliez, M ;
Tran, A ;
Trébéden, H ;
Jaffray, P ;
Malassagne, B ;
Calmus, Y ;
Weill, B ;
Batteux, F .
HEPATOLOGY, 2001, 33 (05) :1173-1180
[84]   PATHOLOGY OF ALCOHOLIC LIVER-DISEASE [J].
FRENCH, SW ;
NASH, J ;
SHITABATA, P ;
KACHI, K ;
HARA, C ;
CHEDID, A ;
MENDENHALL, CL .
SEMINARS IN LIVER DISEASE, 1993, 13 (02) :154-169
[85]  
Friedman JM, 1998, NUTR REV, V56, pS38
[86]   The ins and outs of mitochondrial dysfunction in NASH [J].
Fromenty, B ;
Robin, M ;
Igoudjil, A ;
Mansouri, A ;
Pessayre, D .
DIABETES & METABOLISM, 2004, 30 (02) :121-138
[87]   Impaired mitochondrial function in microvesicular steatosis - Effects of drugs, ethanol, hormones and cytokines [J].
Fromenty, B ;
Pessayre, D .
JOURNAL OF HEPATOLOGY, 1997, 26 :43-53
[88]   INHIBITION OF MITOCHONDRIAL BETA-OXIDATION AS A MECHANISM OF HEPATOTOXICITY [J].
FROMENTY, B ;
PESSAYRE, D .
PHARMACOLOGY & THERAPEUTICS, 1995, 67 (01) :101-154
[89]  
FROMENTY B, FATTY LIVER DIS NASH, P132
[90]  
GALAMBOS JT, 1978, GASTROENTEROLOGY, V74, P1191